D04.60

Clinical Causes: Prolonged exposure to ultraviolet (UV) radiation from the sun or tanning beds Repeated skin injuries or irritation Frequent exposure to certain industrial chemicals or carcinogens Weakened immune system, making the skin more susceptible to abnormal cell growth Pre-existing skin conditions that cause chronic inflammation

Key Symptoms: Persistent, scaly, or rough patches on the skin Lesions that are red, brown, or pink in color Lesions that do not heal or heal very slowly Raised or wart-like growths on the skin Itching or tenderness in affected areas Changes in skin texture or color that persist over time

Diagnosis Path: Diagnosis of carcinoma in situ of the skin generally involves a comprehensive physical examination by a healthcare professional. The physician may assess the lesion’s appearance and characteristics, noting any persistent or abnormal skin changes. Confirmatory diagnosis often requires skin biopsy, where a small sample of tissue from the lesion is examined microscopically for abnormal cell growth. Additional imaging or dermatological tests may be used to evaluate the extent of skin involvement and rule out deeper invasion.

Treatment Protocols: Treatment options for carcinoma in situ of the skin focus on removing or destroying the abnormal cells to prevent progression to invasive cancer. Common treatments include: - Surgical excision: Physically removing the lesion with clear margins - Cryotherapy: Freezing the abnormal tissue with liquid nitrogen - Topical medications: Applying creams or ointments containing chemotherapeutic agents or immune response modifiers - Curettage and electrodessication: Scraping away lesion tissue followed by cauterization - Photodynamic therapy: Using special light and photosensitizing agents to destroy abnormal cells Follow-up care and regular skin examinations are essential to monitor for recurrence or new lesions. Early intervention significantly improves the prognosis of carcinoma in situ of the skin.